Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view

BACKGROUND: The aim of the present retrospective study was to analyze clinical outcome and risk factors associated with treatment outcomes according to KRAS status in patient with metastatic colorectal cancer (mCRC) treated with bevacizumab (bev) plus chemotherapy in the first-line setting. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Bencsikova, Beatrix, Bortlicek, Zbynek, Halamkova, Jana, Ostrizkova, Lenka, Kiss, Igor, Melichar, Bohuslav, Pavlik, Tomas, Dusek, Ladislav, Valik, Dalibor, Vyzula, Rostislav, Zdrazilova-Dubska, Lenka
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4376345/
https://ncbi.nlm.nih.gov/pubmed/25888291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-015-0266-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados